Profile: Hana Biosciences, Inc. is a biopharmaceutical company that develops products to advance cancer care. Our Marqibo® is a novel targeted anti-cancer compound for Non-Hodgkin's Lymphoma and Acute Lymphoblastic Leukemia. Our Alocrest™ is a novel targeted anti-cancer compound for breast and lung cancer. Our Kyrbax™ is a topical compound for skin rashes associated with EGFR inhibitors.
3 Products/Services (Click for related suppliers)
| |||||
• | Topotecan Hydrochloride Injection | • | Vincristine Sulfate Injection | • | Vinorelbine Tartrate Injection |